Disc Medicine Files 8-K: Material Definitive Agreement
Ticker: IRON · Form: 8-K · Filed: Oct 22, 2025 · CIK: 1816736
| Field | Detail |
|---|---|
| Company | Disc Medicine, Inc. (IRON) |
| Form Type | 8-K |
| Filed Date | Oct 22, 2025 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 9 min |
| Key Dollar Amounts | $0.0001, $84.00, $83.9999, $210.9 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-filing
TL;DR
Disc Medicine just signed a big deal, filing an 8-K on 10/20/25.
AI Summary
On October 20, 2025, Disc Medicine, Inc. entered into a material definitive agreement. The company, formerly known as Gemini Therapeutics, Inc. and FS Development Corp., is incorporated in Delaware and headquartered in Watertown, Massachusetts. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
This filing indicates a significant new agreement for Disc Medicine, Inc., which could impact its business operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that are not yet fully understood.
Key Numbers
- 001-39438 — SEC File Number (Identifies the company's filing history with the SEC.)
- 85-1612845 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Disc Medicine, Inc. (company) — Registrant
- October 20, 2025 (date) — Date of earliest event reported
- Gemini Therapeutics, Inc. (company) — Former company name
- FS Development Corp. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- Watertown, Massachusetts (location) — Address of Principal Executive Offices
FAQ
What is the nature of the material definitive agreement entered into by Disc Medicine, Inc. on October 20, 2025?
The filing states that Disc Medicine, Inc. entered into a material definitive agreement on October 20, 2025, but the specific details of this agreement are not provided in the excerpt.
What were the former names of Disc Medicine, Inc.?
Disc Medicine, Inc. was formerly known as Gemini Therapeutics, Inc. and FS Development Corp.
In which state is Disc Medicine, Inc. incorporated?
Disc Medicine, Inc. is incorporated in Delaware.
What is the principal executive office address for Disc Medicine, Inc.?
The principal executive office address is 321 Arsenal Street, Suite 101, Watertown, Massachusetts, 02472.
What is the SEC file number for Disc Medicine, Inc.?
The SEC file number for Disc Medicine, Inc. is 001-39438.
Filing Stats: 2,188 words · 9 min read · ~7 pages · Grade level 13.2 · Accepted 2025-10-22 09:11:57
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share IRON The Nasdaq Global Ma
- $84.00 — mon Stock") at a price to the public of $84.00 per share and (b) in lieu of Common Sto
- $83.9999 — Warrants") at a price to the public of $83.9999 per Pre-Funded Warrant, which represent
- $210.9 m — fering are expected to be approximately $210.9 million, after deducting the underwriting
Filing Documents
- d49689d8k.htm (8-K) — 41KB
- d49689dex11.htm (EX-1.1) — 230KB
- d49689dex41.htm (EX-4.1) — 82KB
- d49689dex51.htm (EX-5.1) — 11KB
- d49689dex991.htm (EX-99.1) — 10KB
- d49689dex992.htm (EX-99.2) — 11KB
- g49689g1021024745079.jpg (GRAPHIC) — 4KB
- 0001193125-25-245871.txt ( ) — 601KB
- iron-20251020.xsd (EX-101.SCH) — 3KB
- iron-20251020_lab.xml (EX-101.LAB) — 18KB
- iron-20251020_pre.xml (EX-101.PRE) — 11KB
- d49689d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. DISC MEDICINE, INC. Date: October 22, 2025 By: /s/ John Quisel Name: John Quisel, J.D., Ph.D. Title: Chief Executive Officer